Summit Therapeutics (SMMT) Property, Plant & Equipment (Net) (2017 - 2026)

Summit Therapeutics (SMMT) Property, Plant & Equipment (Net) (2017 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 642,333.36
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 5.32 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 31.48 Mn
10 Summit Therapeutics 10.29 Bn 9.60 Bn - 1.78 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.78 Mn
Jun 30, 2026 1.78 Mn
Mar 31, 2026 1.66 Mn
Mar 31, 2026 1.66 Mn
Dec 31, 2025 1.06 Mn
Dec 31, 2025 1.06 Mn
Sep 30, 2025 810,000.00
Sep 30, 2025 810,000.00
Jun 30, 2025 690,000.00
Jun 30, 2025 690,000.00
Mar 31, 2025 652,000.00
Mar 31, 2025 652,000.00
Dec 31, 2024 254,000.00
Dec 31, 2024 254,000.00
Sep 30, 2024 265,000.00
Sep 30, 2024 265,000.00
Jun 30, 2024 223,000.00
Jun 30, 2024 223,000.00
Mar 31, 2024 181,000.00
Mar 31, 2024 181,000.00